Win $100-Register

Luigi Mangione pleads not guilty in high-profile murder of CEO Brian Thompson

Luigi Mangione, the man accused of fatally shooting UnitedHealthcare CEO Brian Thompson on a bustling Midtown Manhattan sidewalk, appeared in a New York courtroom on Monday to plead not guilty to state murder and terrorism charges.

This hearing marked Mangione’s first formal response to the allegations brought against him.

Eleven Charges Filed Against Mangione

The 26-year-old is facing 11 charges, including first-degree murder in furtherance of terrorism, two counts of second-degree murder, as well as weapon and forgery charges. Prosecutors from Manhattan District Attorney Alvin Bragg’s office confirmed they are working in coordination with federal authorities to manage the complex case.

“This is not a usual case in terms of the sheer volume of evidence,” prosecutor Joel Seidemann said, citing thousands of hours of video and other materials gathered during the investigation. The defense expressed concerns about Mangione’s ability to receive a fair trial, highlighting the high-profile nature of his extradition and the media frenzy surrounding his case.

Protesters Rally Outside the Courtroom

The courtroom was packed with members of the public, including protesters who rallied outside, waving signs that read “People Over Profit” and chanting, “Health care is a human right.” Mangione has gained an unusual online following, with some framing him as a symbol of frustration toward the U.S. health care system and corporate America.

Inside, Mangione appeared calm as he listened to his attorneys. Dressed in khakis and a maroon sweater, he was escorted in shackles down a courthouse hallway after the hearing. Judge Gregory Carro assured Mangione’s defense that a fair jury would be selected for his trial, which is set to continue on February 21.

A Symbolic Killing and Federal Charges

Mangione’s alleged act, which prosecutors believe was fueled by anger toward the health insurance industry, has drawn national attention. According to the indictment, federal prosecutors claim jurisdiction due to Mangione’s interstate travel to commit the crime and his use of the internet to plan the murder.

In addition to the state charges, Mangione faces a federal indictment that includes murder through use of a firearm, stalking, and other charges. The federal murder charge carries the possibility of the death penalty, while the state charges could result in life imprisonment without parole.

Authorities said Mangione meticulously planned the killing, viewing it as a symbolic attack against corporate greed. His notebook, recovered during his arrest, contained entries expressing hostility toward the health insurance industry, including one that read, “The target is insurance because it checks every box.”

The Evidence Against Mangione

Mangione was arrested on December 9 at a Pennsylvania McDonald’s following a weeklong manhunt. Upon his arrest, police discovered a 3D-printed pistol, a silencer, and false identification documents in his possession. Investigators later matched the weapon to the shell casings found at the crime scene, which were marked with phrases like “deny,” “defend,” and “depose,” seemingly referencing criticism of insurance industry practices.

Surveillance footage captured Mangione purchasing materials used in the attack, and his fingerprints were found on items at the scene. His writings detailed the planning process, with one entry dated August 15 stating, “The details are finally coming together.”

A Complex Legal Battle Ahead

Both state and federal trials will proceed in parallel, with the state trial scheduled to take place first. Prosecutors have not yet decided whether to seek the death penalty in the federal case, a decision that would require approval from the U.S. Attorney General.

The case has sparked widespread debate, drawing attention to growing public dissatisfaction with the health care system and corporate America. As the trials unfold, Mangione’s actions and motivations will remain a focal point of both legal and societal discourse.

ALL Headlines